Ambreen Azhar is a Nephrology physician. OpenAlex indexes 37 publications with 2,185 citations (h-index 12); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
St Lukes Hospital Mount Sinai
1111 Amsterdam Ave
Nyc, NY 10025
Telephone
212-523-3530Registry record last updated 6 Apr 2018.
Clinical trials
- Immune Registry for BK in Kidney Transplant Recipients
Sponsor: Virginia Commonwealth University
- Immune Registry for Organ Transplantation From COVID Positive Donors.
Sponsor: Virginia Commonwealth University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Apellis Pharmaceuticals, Inc.Program year20251 payment
- Veloxis Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
40.4%Beta blocker12.5%Carvedilol76%Propranolol Hcl8%Metoprolol Tartrate7%Metoprolol Succinate6%Labetalol Hcl3%Part D<11 patientsCalcium channel blocker10.8%Nifedipine Er52%Amlodipine Besylate48%Part D≥51 patients+ 9 more classes in this area
Metabolism & gastrointestinal
34.1%Corticosteroid9.5%Prednisone100%Part D≥78 patientsProton pump inhibitor6.5%Pantoprazole Sodium94%Omeprazole7%Part D<11 patients+ 9 more classes in this area
Genitourinary & hormones
10.1%alpha-Adrenergic Blocker7.8%Tamsulosin Hcl100%Part D≥58 patients5-alpha Reductase Inhibitor2.2%Finasteride100%Part D≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- CMV T-Cell Immunity Assay Based Guidance to Interrupt Prophylaxis in Intermediate Risk Kidney Transplant Patients
American Journal of Transplantation
2025 - Post-Transplant Oxalate Burden and Renal Injury: Insights from Molecular and Histologic Analysis
American Journal of Transplantation
2025 - Molecular and Histological Insights into BK Virus-Associated Nephropathy in Kidney Transplant Recipients
American Journal of Transplantation
2025 - "Immune Predictors of BK Viremia Clearance: Role of BK Virus-Specific T-Cell Immunity in Kidney Transplant Recipients"
American Journal of Transplantation
2025 - Longitudinal Assessment of BK Polyoma Virus Specific Immune Responses After Kidney Transplantation
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”